Federal award
KBR WYLE SERVICES, LLC
0186
Contract
Obligated and Ceiling
- Obligated (net)
- $18,548,475.09
- Ceiling (potential value, not spending)
- $18,589,722.00
- Current value
- $18,589,722.00
- Gross positive obligations
- $18,589,722.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · KNV8E5VRLHT9
- Owner company
- KBRBasis reviewed link: a dated, evidenced ownership link.
- Reported parent
- KBR, INC. · VJ3XVZC76HT9
- Awarding agency
- Department of Defense · sub-agency 9763 · office S0107A
- Funding agency
- Department of Defense · sub-agency 5700
- Product or service (PSC)
- AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
- PIID
- 0186
- Parent vehicle (IDV PIID)
- HC104705D4005
- Award type code
- C
- Actions
- 14 · Mar 30, 2011 to Feb 5, 2019
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History14
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 5, 2019 | FY2019 | 1A | C | −$41,246.91 | |
| Aug 5, 2013 | FY2013 | 12 | C | $1,006,124.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 1, 2013 | FY2013 | 11 | C | $1,568,854.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 29, 2013 | FY2013 | 10 | C | $1,858,829.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 1, 2013 | FY2013 | 9 | C | $1,200,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 12, 2013 | FY2013 | 8 | C | $530,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 23, 2013 | FY2013 | 7 | C | $1,033,250.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 26, 2012 | FY2012 | 6 | C | $2,503,400.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 13, 2012 | FY2012 | 5 | C | $1,100,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 24, 2012 | FY2012 | 4 | C | $2,338,515.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 9, 2012 | FY2012 | 3 | C | $33,800.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 5, 2012 | FY2012 | 2 | C | $3,152,929.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 23, 2011 | FY2011 | 1 | C | $128,080.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 30, 2011 | FY2011 | 0 | — | $2,135,941.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.